New vaccine formula passes first safety check in healthy volunteers
NCT ID NCT06611033
First seen Jan 22, 2026 · Last updated May 19, 2026 · Updated 18 times
Summary
This early-stage study tested a new vaccine formula (V118 Formulation C) in 65 healthy adults to see if it is safe and well-tolerated. Researchers monitored side effects like injection-site reactions and other health events. The study is complete, and results will guide further development of the vaccine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Centers of America ( Hollywood ) ( Site 0002)
Hollywood, Florida, 33024, United States
-
University of Texas Medical Branch ( Site 0001)
Galveston, Texas, 77555-1115, United States
-
Velocity Clinical Research, Hallandale Beach ( Site 0003)
Hallandale, Florida, 33009, United States
Conditions
Explore the condition pages connected to this study.